Today: 24.Sep.2018
Molybdenum 99 Production for Nuclear Medicine 2010 - 2020 Europe
17.Mar.2015
Rate this item
(0 votes)

AIPES - The radionuclides supply for nuclear medicine is crucially dependent on an unsustainably low number of production reactors and processing facilities in Europe, North America, South-Africa and Asia/Pacific.

Read 1882 times Last modified on Thursday, 04 January 2018 17:02

Newsletter Subscription

  • Latest
  • Popular
  • Jeff Johnson, Chemical & Engineering News: The…
  • Senator Lisa Murkowski, Alaska: As our nuclear…
  • Clinton Crackel, Co-Founder, Nuclear Fuels Reprocessing Coalition:…
  • Clinton Crackel, Co-Founder, Nuclear Fuels Reprocessing Coalition:…
  • Praveen Duddu: Eight of the 10 largest…